The Metsera deal is about winning the obesity drugs’ market that’s expected to reach US$100 billion by 2030. Read More Post navigation DOJ moves to subpoena ex-CIA head Brennan on Trump-Russia probe Pfizer to buy Metsera for $13 billion, capping bidding war